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a  b  s  t  r  a  c  t
Rotavirus  (RV)  cores  were  released  from  double-layered  particles  (DLPs)  by  high  concentrations  of CaCl2,
puriﬁed  and  ‘opened’  by treatment  with  EDTA  or  EGTA.  Under  appropriate  in  vitro  conditions  DLPs  have
been  shown  to have  transcriptase  and  ‘open  cores’  replicase  activity.  Furthermore,  it has  been  demon-
strated that transcriptase  activity  and  infectivity  of  native  cores  can  be  restored  by  transcapsidation
with  VP6,  VP7  and  VP4.  The  missing  link  for  particle  reconstitution  in  vitro  has  been  the manipulation
of  ‘open  cores’  to become  functionally  active  cores  again.  The  experiments  described  here  were  under-
taken  with  the  aim  of  exploring  packaging  of  RV  RNAs  into  opened  cores  in  vitro.  Rotavirus  cores  were
opened by  approximately  200 M  EGTA,  leading  to  the  release  of genomic  dsRNA.  Conversely,  RV  cores
were  found  to  be stable  in  the  presence  of minimum  concentrations  of Ca2+, Mg2+, spermidine3+ and
cobalthexamine3+ of  between  40 and  300  M. Aggregates  of puriﬁed  cores  were  resolved  in the  presence
of  0.3  mM  deoxycholate  (minimum  concentration).  Core  shells  opened  with  EGTA  were  reconstituted
by  the  addition  of di-  or  trivalent  cations  within  2 min  of  the  opening  procedure.  Addition  of  puriﬁed,
baculovirus  recombinant-expressed  VP6  to  native  and  reconstituted  cores  led to the  formation  of  DLPs
or DLP-like  particles,  which  upon  transfection  into  MA104  cells  were  infectious.  The  rescued  infectivity
likely  originated  in  part  from  unopened  and  in  part  from  reconstituted  cores.  Radiolabelled  RV (+)  ssR-
NAs  could  be packaged  into  reconstituted  cores  and  DLPs,  as  indicated  by resistance  to  RNase  I digestion.
The packaging  reaction  was,  however,  not  RV  RNA  sequence-speciﬁc,  since  unrelated  ssRNAs,  such as
those  transcribed  from  HIV-2  cDNAs,  were  also packaged.  The  kinetics  of  packaging  of  homologous  and
heterologous  RNAs  were  similar,  as  evidenced  by competitive  packaging  assays.  None  of  the  packaged
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1. Introduction
Rotaviruses (RVs) are a major cause of acute gastroenteritis
in infants and young children and impose a heavy disease bur-
den worldwide resulting in substantial mortality (450,000–500,000
children of <5-year-old/annum), mainly in developing countries
in sub-Saharan Africa, Asia and S America (Parashar et al., 2003,
2009; Tate et al., 2012). Two live, attenuated RV vaccines have
been licensed in over 100 countries since 2006 and are in wide
use (Desselberger et al., 2009; Yen et al., 2011) with so far very
encouraging outcomes in relation to the reduction of hospitali-
sation for RV-associated acute gastroenteritis (AGE) and also of
mortality (Yen et al., 2011; Patel et al., 2012; Soares-Weiser et al.,
2012; Gastan˜aduy et al., 2013; Lee et al., 2013).
Open access under CC BY-NC-SA license.Rotavirus propagation is naturally initiated by an infectious
virus particle (virion) adsorbing to a susceptible cell via speciﬁc
cellular receptors, followed by the steps of a viral replication cycle:
penetration, uncoating, transcription, translation, viral nucleic acid
icense. 
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eplication, assembly of viral components (morphogenesis), and
elease of virions by cell lysis. Rotavirus early morphogenesis and
iral RNA replication take place in cytoplasmic inclusion bodies
ermed ‘viroplasms’ (Estes and Greenberg, 2013).
It has been possible to mimic  and explore portions of the viral
orphogenesis in vitro. Virions, consisting of triple–layered par-
icles (TLPs), can be stripped ﬁrst of their outer layer (containing
P7 and VP4) by mild EDTA treatment (Estes et al., 1979) to
btain double-layered particles (DLPs). From those the middle layer
consisting of VP6) can be removed in the presence of high con-
entrations of CaCl2 (Bican et al., 1982) to obtain ‘core’ particles.
Similar procedures have been used to prepare cores of LA virus
Naitow et al., 2001).] The core particles contain the 11 genomic
egments of dsRNA, the RNA-dependent RNA polymerase (RdRp,
P1) and the capping enzyme (VP3) within a scaffold made of VP2.
he structure of these components within the core has been studied
n some detail (Prasad et al., 1996; Lawton et al., 1997; Pesavento
t al., 2003; McClain et al., 2010; Settembre et al., 2011; Trask et al.,
012a,b; Estrozi et al., 2013), and structure–function relationships
f the RdRp complexed with RNA, VP3, and VP2 have been explored
Lu et al., 2008; Ogden et al., 2012; Trask et al., 2012a,b). Isolated
mpty core-like particles have been obtained from VP2-expressing
aculovirus recombinants, but found to be tightly cell-associated.
nly the mild detergent deoxycholate (DOC) and SDS were able
o solubilise VP2 (Labbé et al., 1991). At high concentrations of
ecombinant-expressed VP2, unusual forms (helix-like structures)
ere observed (Zeng et al., 1994).
DLPs and core particles are non-infectious in conventional cell
ulture infection assays. However, by successive addition (tran-
capsidation) of VP6, VP7 and VP4 to core particles in vitro, it
as possible to partially reconstitute infectivity (Chen and Ramig,
993a,b), and by careful quantitation of the in vitro transcapsida-
ion system full infectivity could be restored (Trask and Dormitzer,
006). Trans-capsidation of native cores with VP6 alone restores
ranscriptase activity (Kohli et al., 1993) which in turn can be
nhibited by reacting the DLPs with monoclonal antibodies directed
o VP6 (Kohli et al., 1994; Thouvenin et al., 2001). Upon transfec-
ion into susceptible cells DLPs are infectious (Bass et al., 1992;
hen and Ramig, 1993b). Native RV cores can be destabilised by
ialysis against low salt buffer containing low concentrations of
DTA. Such preparations, termed ‘open cores’, accept externally
dded single-stranded (ss) RV RNA molecules of positive (+) polar-
ty and of homologous or heterologous origin (i.e. from a different
V strain) as templates for RNA replication in vitro to yield dsRNA
Chen et al., 1994; Tortorici et al., 2003). Biochemically Zeng et al.
1996) deﬁned a complex of VP1, VP2 and (+) ssRNA as the mini-
al  replicase particle. The missing link for particle reconstitution
ompletely in vitro is the ability to reconstitute cores out of their
omponents in vitro to obtain functionally active structures.
Patton’s group has shown that viral RNA replication occurred
imultaneously with packaging of viral ssRNA into cores (Gallegos
nd Patton, 1989; Patton and Gallegos, 1990), and the detailed con-
itions of minus-strand RNA synthesis were worked out (Chen and
atton, 1998, 2000; Patton et al., 1996; Wentz et al., 1996; Patton
t al., 1999; Tortorici et al., 2003). In addition, biochemical func-
ions of open cores have been analysed (Chen et al., 1999; Patton
nd Chen, 1999).
Two RV nonstructural proteins, NSP2 and NSP5 (encoded by
V RNA segments 7,8, or 9 [depending on strain] and 11, respec-
ively), are essential for the formation of viroplasms and thus for
V replication (Berois et al., 2003; Campagna et al., 2005; Eichwald
t al., 2002, 2004; Fabbretti et al., 1999; Patton, 2001; Patton et al.,
997; Schuck et al., 2001; Silvestri et al., 2004; Taraporewala et al.,
999; Taraporewala and Patton, 2001; Torres-Vega et al., 2000;
asquez-Del Carpio et al., 2004). The packaging of the 11 segments
f RV RNA is very tightly controlled, but the mechanisms governingarch 178 (2013) 252– 263 253
packaging are unknown. Primary replication complexes (consisting
of one ss(+)RNA, VP1 and VP3, possibly attached to VP2) may specif-
ically interact to form a native core, or ssRNAs may be pulled into
preformed empty cores (concerted vs core-ﬁlling model, McDonald
and Patton, 2011). For RVs, there are better arguments for the con-
certed than the core-ﬁlling packaging mechanism. When native
cores are opened, the genomic dsRNA molecules are released (Chen
et al., 1994). They cannot be repackaged, due to their intrinsic stiff-
ness and rigidity as isolated molecules in solution (Kapahnke et al.,
1986). Early attempts to introduce RV ss(+)RNA constructs into
viroplasms in order to have them rescued into infectious progeny
virus have failed (Gorziglia and Collins, 1992; Silvestri et al., 2004).
Our long term aim is to ﬁnd conditions permitting rescue of infec-
tivity by reconstruction of RV particles in vitro from its components.
Until now, only helper virus-dependent systems have succeeded in
rescuing transfected or intracellularly produced RV RNA segments
into infectious progeny (Komoto et al., 2006; Trask et al., 2010;
Troupin et al., 2010).
The early steps of RV morphogenesis constitute a very complex
and over large parts unexplored process that has so far resisted
manipulations intended to rescue infectivity from engineered pri-
mary components. The work described here was carried out to
further characterise rotavirus cores, to study conditions of their
structural stability, and to explore mechanisms by which RV (+)
ssRNA is packaged. It is shown that core particles opened in vitro
can be reconstituted and that transcapsidation of such core struc-
tures is possible. In vitro conditions are described permitting the
packaging of RV ssRNAs into opened cores. However, the packaging
of ssRNAs is sequence-non-speciﬁc since HIV-2 RNAs transcribed
in vitro from cDNA fragments are also packaged, and since speci-
ﬁcity could not be demonstrated by competitive packaging assays.
So far, rescue of infectivity from in vitro packaged RV particles has
not succeeded.
2. Materials and methods
2.1. Viruses and cell culture
The bovine RV RF strain (G6 P6[1]) and the porcine RV OSU
strain (G5P9[7]) were used. Rotavirus was  propagated on conﬂuent
monolayers of MA104 cells or KJ cells (another embryonic monkey
kidney cell line transduced with the gene encoding the V protein
of SV5, as described for other cell lines by Young et al. (2003))
in the presence of 0.5 g/ml of trypsin (Sigma type IX-S, cat. No.
0303) as previously described (Graham et al., 1987; Arnoldi et al.,
2007). Infectivity titers were measured using standard procedures
and recorded as TCID50/ml. Recombinant baculovirus was grown
on Spodoptera frugiperda (Sf9) cells in suspension or as monolayers
at 26 ◦C in Hinks medium supplemented with 10% fetal calf serum
as described (Charpilienne et al., 2001; Cohen et al., 1989).
2.2. Virus puriﬁcation and protein concentration
Rotavirus was puriﬁed from cell cultures infected at low m.o.i.
after the appearance of complete CPE by ultracentrifugation,
decaﬂuoropentane (Vertrel XF, Dupont) extraction of the pellet sus-
pension, and two subsequent equilibrium ultracentrifugation steps
on CsCl gradients essentially as described by Patton et al. (2000)
and Arnoldi et al., 2007. Two well separated gradient bands were
obtained which contain TLPs (density 1.36 g/ml) and DLPs (den-
sity 1.38 g/ml). TLP and DLP suspensions were desalted by passing
over G25 coarse Sephadex columns (0.7 cm3 column per 50 l of
virus in CsCl). The protein concentration of twice CsCl gradient-
puriﬁed suspensions of TLPs and DLPs was  determined by use of the
Coomassie Protein Assay Reagent of Pierce (Perbio Science France)
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r by the Bradford assay (BioRad), following the manufacturers’
nstructions. Serial twofold dilutions of a solution of 2 mg/ml  of
ovine serum albumin were used as standards. In addition, RV
LP and DLP preparations were analysed by micro spectrophoto-
etry (Nanodrop 1000, Thermo Scientiﬁc) by which maxima of
he spectra were seen at 260 nm wavelength. OD values at 260 nm
avelength were correlated with protein content measured in par-
llel, and the following relationship was established: [Protein in
g/ml] = OD260 × 68.3 (N = 41; r = 0.900; P < 0.001). The numbers of
articles was estimated from the total MW of their protein compo-
ents.
.3. Preparation of viral mRNA from DLPs
The DLPs from CsCl gradient puriﬁed rotavirus were used
o transcribe viral mRNA in vitro, either unlabelled or labeled
ith [32P]-UTP, and then extracted with phenol/chloroform, as
escribed by Patton et al. (2000) and Charpilienne et al., 2002.
.4. Cloning of rotavirus cDNA and of rotavirus cDNA fusion
onstructs
Complementary DNA (cDNA) of dsRNA segments of RV strain
SU (G5P9[7]) was made and cloned into the pcDNA3 vector (Invi-
rogen) as described by Afrikanova et al. (1998) and Fabbretti et al.
1999).
.5. In vitro transcription of cDNA constructs
Rotavirus cDNA clones were ampliﬁed with primers carrying the
7 polymerase promoter sequence (5′end) and suitable restriction
ndonuclease sites for deﬁning the exact 3′end. Amplicons were
ynthesised by PCR using KOD polymerase (Novagen) according to
he manufacturer’s protocol. Thermocycler conditions were: 95 ◦C
or 2 min, 40 cycles of 95 ◦C for 20 s, 63 ◦C for 30 s, 70 ◦C for 3 min,
ith a ﬁnal extension at 70 ◦C for 10 min. Amplicons were puri-
ed using a Qiagen PCR column cleanup kit and digested in TAS
uffer (30 mM  Tris acetate, 65 mM KOAc, 10 mM MgOAc, 0.5 DTT,
.5 mM BSA, 0.4 mM spermidine dihydrochloride, pH 7.9) with the
ppropriate restriction endonucleases (Promega) for 2 h at 37 ◦C
rior to re-puriﬁcation with a Qiagen Minelute kit according to the
anufacturer’s instructions.
In vitro transcription was carried out using the MEGAscript T7
it (Ambion) according to the manufacturer’s instructions. RNA
as synthesised either unlabelled or was radiolabelled with 10 uCi
f -32P-UTP (NEN, speciﬁc radioactivity 3000 Ci/mM). For radio-
abelling experiments, the concentration of unlabelled UTP used
as one tenth of the concentration used for non-radioactive RNA
ynthesis. After transcription the reaction mixture was  treated
ith DNase and then puriﬁed by proteinase K treatment, phenol-
hloroform extraction and ethanol precipitation; the pellets were
esuspended in small volumes of nuclease-free distilled water.
lternatively, RNA transcripts were puriﬁed by the Qiagen Mine-
ute RNA puriﬁcation kit. The products were checked for size and
omogeneity by electrophoresis on 0.8% agarose gels in 20 mM
OPS-Tris buffer pH 7.7, followed by staining with ethidium
romide or autoradiography. Puriﬁed RNAs were quantitated by
anodrop spectrophotometry.
Heterologous ssRNAs were derived from HIV-2 cDNA fragments
s described below..6. Preparation of virus cores and core-like particles
Viral cores were prepared from puriﬁed DLPs by treatment with
.2 M CaCl2, followed by ultracentrifugation at 90,000 × g (Beckmanarch 178 (2013) 252– 263
TLA100.4) and 4 ◦C for 15 min  and resuspension in water (Bican
et al., 1982) or in 200 M CaCl2
Alternatively, viral core-like particles (CLPs-VP1/VP2/VP3) were
prepared from baculovirus recombinant-expressed DLP-like par-
ticles (DLPs-VP1/VP2/VP3/VP6) (Zeng et al., 1996) by similar
treatment.
2.7. Puriﬁcation of rotavirus protein VP6
Baculovirus recombinant expressed protein VP6 of the bovine
RV RF strain was puriﬁed as described (Charpilienne et al., 2002).
In brief, infected Sf9 cells were harvested at 3–5 days post infec-
tion, and the clariﬁed supernatant was centrifuged in a Beckman
45 Ti rotor at 80,000 × g and 4 ◦C for 30 min. The pellet was
resuspended in 50 mM MOPS (3-(N-morpholino)propanesulfonic
acid) buffer, pH 6.0, adjusted to 0.3 M CaCl2 and centrifuged at
13,000 × g for 10 min. The supernatant containing puriﬁed VP6 was
dialysed against water (nitrocellulose ﬁlter, 25 nm, Millipore) at
room temperature for 10 min. Under these conditions, VP6 was
obtained that had assembled to large polymers (tubules) (Lepault
et al., 2001), and such preparations were used for reconstruction
assays.
2.8. Reconstitution experiments with ‘opened cores’
Virus cores prepared from DLPs (see above) were ‘opened’ by
treatment with 0.5–1 mM  EGTA or EDTA, similar to the procedure of
Chen et al (1994), but in a more controlled way. All reactions were
in Hepes buffer, 10–50 mM,  pH 7.4 or in 50 mM Tris–HCl buffer
pH 7.4 if not otherwise stated. Reconstitution of core structures
was  explored by the addition of 2–5 mM  MgCl2, CaCl2, spermidine
(Invitrogen) or cobalthexamine chloride (Fluka) at time intervals
over several minutes after the start of the EGTA treatment. Puriﬁed
recombinant VP6 (see above) was  then added to reconstitute DLP-
like structures.
In order to deﬁne the conditions of stabilisation of cores as
tightly as possible, some experiments were carried out using EGTA-
buffered calcium calibration solutions with known concentrations
of free Ca2+ and EGTA buffer with known amounts of Mg2+ ions
added (Molecular Probes Inc., Eugene, OR 97402-9132, USA).
2.9. Packaging of RV and heterologous RNAs into ‘opened cores’
Rotavirus cores (60 ng, approximately 5 × 108 particles) were
opened with 800 M EGTA in the presence of RV mRNA or heterol-
ogous ss RNAs, alone or in mixtures (in competition experiments),
and radiolabelled or unlabelled, for 2 min  and then a packag-
ing cocktail was added. The latter was  derived from a packaging
reaction used by Qiao et al. (1995) for packaging work with bacte-
riophage phi6 and contained the following components (in ﬁnal
concentrations): Tris–HCl, pH 7.4, 15 mM;  MgCl2, 1 mM;  MnCl2
300 M;  NaCl 8 mM;  dithiothreitol, 1 mM;  Na2EDTA, 80 M;  rNTPs,
250 M each; RNase inhibitor, 1 unit [RNasin, N Engl Biolabs]; PEG
4000, 1–3%). The ﬁnal concentration of EGTA present was  600 M,
radiolabelled viral RNAs were present at 10 ng/20 l, and unla-
belled viral RNAs at 30–150 ng/20 l. Radiolabelled RNA associated
with reconstituted cores which was  resistant to treatment with
RNase ONE was  considered as packaged (Qiao et al., 1995). Cores
treated in this way  were transcapsidated with recombinant VP6
as described above. Reconstituted core structures or DLPs (pro-
duced by transcapsidation) were treated with 10 units of RNase
I (Promega) at room temperature for 15 min, following the pro-
cedure of Qiao et al., 1995, and then analysed by agarose gel
electrophoresis as described below.
In order to test for the speciﬁcity of packaging, the following
RNAs were produced:
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Table 1
Minimum concentrations of reagents to open and stabilise rotavirus cores.
Reagent Action Minimum
concentration
EGTA Open cores in Ca2+ and Mg2+ free solution 200 M
Ca2+ Stabilise cores in EGTA buffered solution 50 M
2+U. Desselberger et al. / Viru
RV:
RNA segment 7 (encoding NSP2), transcribed in vitro from a T7
romoter containing plasmid, 1061 nt; RNA segment 11 (encoding
SP5), transcribed in vitro from a T7 promoter containing plasmid,
67 nt (Fabbretti et al., 1999)
HIV:
RNA fragment of HIV-2 ROD strain, nt pos 514-1618, transcribed
n vitro from an RT-PCR amplicon in reverse orientation, 1104 nt;
NA fragment of HIV-2 ROD strain, nt pos 1-751, transcribed in vitro
rom RT-PCR amplicon in forward orientation, 751 nt.
RNAs were transcribed in vitro, either in the presence of unla-
elled rNTPs, or in the presence of -32P-UTP as described above.
.10. Transfection assays with subviral particles
Transfections were carried out as described (Bass et al., 1992;
hen and Ramig, 1993b), using Lipofectamine 2000 (Invitrogen)
ccording to the manufacturer’s instructions.
.11. Electrophoresis
Using a slight modiﬁcation of the procedure described by
allegos and Patton (1989), samples were analysed on 0.6% non-
enaturing agarose (Invitrogen) minigels using 10–20 mM MOPS
uffer adjusted to pH 7.7 with 1 M Trizma base. Electrophoresis
as at 90 V and 20–22 mA  until the dye marker bromophenol blue
ad reached the bottom of the gel. Gels were then stained wet
ith 0.5 g/ml of ethidium bromide dissolved in electrophoresis
uffer, or dried and silver-stained, initially using the BioRad Silver
tain Plus kit following manufacturer’s instructions (Charpilienne
t al., 2002). Alternatively, the silver staining procedure as origi-
ally published by Gottlieb and Chavko (1987) was used. All gels
ere photographed and the images stored by computer (using
dobe Photoshop and Image Twain software).
Densitometry was carried out using the image J system
http://rsbweb.nih.gov/ij/).
.12. Electron microscopy
Samples were applied to air-glow-discharged carbon-coated
rids, blotted immediately with ﬁlter paper for 1–2 s, and nega-
ively stained with 1% uranyl acetate solution for 2 × 5 s. The grids
ere examined in a Philips CM12 electron microscope operated at
0 keV (Erk et al., 2003).
.13. Dynamic light scattering
The measurements were carried out at 16 ◦C with a DynaPro-99
 instrument equipped with a temperature-controlled microsam-
ler (Protein Solutions). A sensitivity of 30% was used. The
easurements were performed using 13 l of particle suspension
n water. The detergent deoxycholate (DOC) was added at various
oncentrations up to a ﬁnal concentration of 450 M.  Two or three
ndependent measurements of 20 acquisitions were carried out for
ach experiment. The data were analysed using the Dynamics 4.0
oftware with correlator ﬂex-99. The refractive index and viscos-
ty of water were applied. The percentage of mass distribution was
lotted against different Rh(M) values, and the calculated mean
ydrodynamic radius [Rh(M)] and the polydispersity index (PI, in
ercent) values are indicated..14. Statistics
Slopes and intercepts of the kinetics of competitive packag-
ng reactions were calculated by the method of linear regression.Mg Stabilise cores in EGTA buffered solution 300 M
Spermidine3+ Stabilise cores in buffered solution 50 M
Cobalthexamine3+ Stabilise cores in buffered solution 40 M
Differences in the slopes and intercepts were assessed by the
ANCOVA test (http://ude1.edu/∼mcdonald/statancova.html).
3. Results
Titration of divalent and trivalent cation concentrations
required to stabilise RV cores and action of chelating agents.
One of us (J.C.) had previously observed (2002, unpublished) that
the core-disintegrating effect of chelating agents could be antago-
nised by simultaneous addition of divalent cations (Fig. 1A). Native
rotavirus cores (intact controls in lanes 3 and 8) were opened by
1 mM  EDTA (lane 4) or 1 mM EGTA (lane 5), but, as expected, this
event was  prevented by the simultaneous addition of 5 mM CaCl2
(lane 7) or 5 mM  MgCl2 (lane 6). The same concentrations of MnCl2
or ZnCl2 did not have this effect (results not shown). Opening of
the core liberates the genomic RV dsRNA segments (Fig. 1A, lanes
4, 5; Fig. 1B, lanes 4, 5). The minimal concentration of EGTA to open
cores is approximately 200 M (Fig. 1B). This was  conﬁrmed by re-
titration with more narrowly spaced dilutions of EGTA (results not
shown). Since EGTA chelation is more Ca2+ speciﬁc, we decided to
use EGTA for all subsequent experiments.
Using the same procedure and EGTA-buffered calibration solu-
tions with deﬁned concentrations of free Ca2+ and Mg2+ ions
(Molecular Probes, Eugene, OR, USA), we  determined the mini-
mum free Ca2+ and Mg2+ concentrations stabilising the cores to
be 50 M and 300 M,  respectively (Table 1). Divalent cations
could be replaced by trivalent cations, such as spermidine3+ and
cobalthexamine3+, which were found to stabilise cores at minimal
concentrations of 40–50 M (Table 1).
3.1. Isolated rotavirus cores form aggregates
Isolated native cores have the tendency to form aggregates.
Puriﬁed rotavirus DLPs and cores were studied by dynamic light
scattering (DLS) to determine the mean particle size and char-
acterise the homogeneity (polydispersity index, PI, in percent) of
the suspensions. DLPs presented in a very monodisperse distri-
bution (PI 9%) of particles of approximately 32 nm hydrodynamic
radius and were used as a calibrator (Supplementary Figure S1A).
Untreated puriﬁed cores were very polydisperse (PI 34%): the non-
symmetrical form, the apparent median radius of 62 nm and the
width of the peak reﬂected the presence of aggregates of het-
erogeneous size (Supplementary Figure S1B). Treatment of core
suspensions with electrolytes (0.5 M NaCl or 5 mM  MgCl2) or with
buffers of different pH (5–9) did not result in major changes
(results not shown). However, treatment with deoxycholate (DOC)
at submillimolar concentrations (80–450 M)  produced a more
homogeneous, and closer to monodisperse suspension (PI 20%) of
particles of 25 nm radius (Supplementary Figure S1D): the transi-
tion of core aggregates to a virtually monodisperse suspension was
achieved at approximately 300 M of DOC (Supplementary Figure
S1C). These observations strongly suggest that it were hydropho-
bic rather than electrostatic forces that produced the particle
aggregation. In the native core suspension aggregates will con-
tain an average of approximately 15 core particles/aggregate. The
DLS measurements of the hydrodynamic radii of monodisperse
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Fig. 1. (A) Effect of chelating agents EDTA/EGTA and of divalent cations (Mg2+, Ca2+) on native RV cores, Agarose gel 0.6%, electrophoresis with 10 mM MOPS/Tris buffer, pH
7.7,  followed by silver staining. Lane 1: TLPs of bovine RV RF strain (slightly degraded to DLPs); lanes 2, 9: DLPs; lanes 3, 8: native RV cores; lane 4: cores + 1 mM EDTA; lane 5:
cores  + 1 mM EGTA; lane 6: RV cores + 1 mM EGTA + 5 mM MgCl2 (simultaneously); lane 7: RV cores + 1 mM EGTA + 5 mM CaCl2 (simultaneously). All reactions and reagents
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gere  in 20 mM Hepes buffer, pH 7.4. The large segments of genomic RNA (s1–s3) ar
garose gel 0.6%, electrophoresis with 10 mM MOPS/Tris buffer, pH 7.7, followed by
f  RV cores with EGTA at concentrations of 1 mM,  200 M,  20 M, 2 M, respective
otavirus cores and DLPs are in excellent agreement with previously
btained cryo-EM data (Prasad et al., 1988; Yeager et al., 1990).
.2. Opening of cores by EGTA can be blocked by subsequent
ddition of divalent cations
Blockage of core opening within short time periods is demon-
trated in Fig. 2. The ﬁrm band of core particles (Fig. 2, lane 3) is
eplaced by a smear spanning an area from slightly above the core
and to a band above RNA segment 1 (Fig. 2, lane 4). When a 4-
olar excess of divalent cations (Mg2+) was added at 30–60 s after
he start of a mild EGTA treatment (with 2× the minimal concen-
ration required to open cores), the destabilisation of core particles
as partially blocked (Fig. 2, lanes 5 and 6); this was in contrast
o cores being protected upon simultaneous addition of the two
eagents (Fig. 2, lane 7; Fig. 1A, lane 6). Recovery of stabilised core
tructures was not possible when divalent cations were added later
han 2 min  after the start of the EGTA treatment (results not shown).
artial recovery of cores (Fig. 2, lane 6) by addition of Mg2+ at 60 s
fter the start of EGTA treatment is improved in the presence of
00–400 mM NaCl (Fig. 2, lanes 8–10). Viral genomic dsRNA seg-
ents have to a large extent been released (Fig. 2, lanes 4–10), but
robably not completely (see below).
In order to test the stability of reconstituted core structures,
hey were opened with 400 M EGTA, treated with 1.6 mM CaCl2
fter 60 s in the presence of 100 mM NaCl, followed by the addition
f 1.6 mM EGTA after 30 min: now the cores could not be opened
results not shown).
Empty core-like particles (produced by treatment of DLP-like
articles containing VP1, VP2, VP3 and VP6 with chaotropic agent)
ere not broken up by treatment with 10 mM EGTA, i.e. 50× the
oncentration of molecules sufﬁcient to open native cores (Sup-
lementary Figure S2), suggesting that fragmentation (‘opening’)
f native cores by EGTA was due to chelation of divalent cations
hich neutralised the excess of negative charges of the enclosed
enomic dsRNA segments. in lanes 4 and 5. (B) Titration of EGTA concentration enabling opening of RV cores.
 staining. Lane 1: TLPs; lanes 2, 8: DLPs; lane 3: native RV cores; lanes 4–7: mixture
Effect of the addition of recombinant VP6 to native cores and
reconstituted core structures
3.3. VP6 was produced in and puriﬁed from VP6-expressing
baculovirus recombinant-infected Sf9 insect cell cultures.
Puriﬁed VP6 was  added to cores that had been opened by EGTA
and then been treated with Mg2+ 60 s later. The results are shown
in Fig. 3. Upon addition of VP6, cores treated with EGTA and then
Mg2+ 60 s later (Fig. 3, lane 4), formed complexes (DLP-like struc-
tures) larger than cores (Fig. 3, line 6), migrating between cores
(Fig. 3, lines 2, 4) and DLPs (Fig. 3, line 1) and some migrating
slower than DLPs. [Fig. 3, lane 3 shows irreversible decomposition
of core structures.]. Particles opened with EGTA and treated with
VP6 directly (with no Mg2+ added; Fig. 3, lane 5) formed structures
similar to those seen in lane 6 (reconstituted cores transcapsidated
with VP6 in the presence of Mg2+), but DLP-like structures were less
abundant. Very similar effects to those observed with Mg2+ were
recorded when the polycations spermidine3+ (Fig. 3, lanes 7, 8) or
cobalthexamine3+ (Fig. 3, lanes 9, 10) were used.
3.4. Electron microscopy
Puriﬁed cores (in 75 mM Tris–HCl buffer, pH 7.4) appear as reg-
ular hexa- to polygonal particles with a smooth surface. There were
very few free dsRNA molecules seen (Fig. 4A). After treatment with
600 M EGTA for 1 min (Fig. 4B) virtually all core particles have
changed: the VP2 layer is marginalised, and the particles appear
as empty shells (containing the contrast dye). Inside the VP2 layer
little ‘knobs’ in 5-fold symmetry were observed that correspond
to VP1/VP3 complexes (demonstrated by staining with VP1- and
VP3-speciﬁc guinea pig antibodies followed by anti-guinea pig
IgG immunogold-labelled secondary antibody; Desselberger, Lever
and Crowther, unpublished results). Plenty of dsRNA molecules
were seen outside of particles (Fig. 4B and Supplementary Figure
S3), many of them with ‘knobs’ (VP1/VP3 complexes) attached to
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Fig. 2. Partial stabilisation of opened RV cores in vitro by the addition of Mg2+ ions. Agarose gel 0.6%, electrophoresis with 10 mM MOPS/Tris buffer, pH 7.7, followed by silver
s tive RV
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Etaining. Lane 1: TLPs (partially degraded to DLPs); lanes 2 and 11: DLPs; lane 3: na
fter 30 s; lane 6: cores + 400 M EGTA + 1.6 mM MgCl2 after 60 s; lane 7: cores + [40
ane  6 in the presence of NaCl 100 mM (lane 8), 200 mM (lane 9), and 400 mM (lane
hem. A time course of core treatment with EGTA demonstrated
n increasing decomposition of their protein components after
ore than 2 min  from the beginning of the treatment (results not
hown). EGTA-treated core particles that were reacted after 1 min
ith 2.5 mM  MgCl2 (Fig. 4C) appeared to be ‘stabilised’. Some cores
eemed to acquire a rough surface, and some of them appeared
ig. 3. Formation of rotavirus DLPs and intermediates by addition of recombinant VP6 to c
garose gel 0.8%, electrophoresis with 10 mM MOPS/Tris buffer, pH 7.7, followed by 
ane  3: cores + 400 M EGTA; lane 4: cores + 400 M EGTA + 1.6 mM MgCl2 after 1 min;
fter 1 min  + VP6; lane 7: cores + 400 M EGTA + 300 M spermidine3+ after 1 min; lane 8
GTA  + 350 M cobalthexamine3+ after 1 min; lane 10: cores + 400 M EGTA + 350 M co cores; lane 4: cores + 400 M EGTA; lane 5: cores + 400 M EGTA + 1.6 mM MgCl2
 EGTA +1.6 mM MgCl2] used simultaneously; lanes 8–10: reactions as described for
ll reactions were in 10 mM Hepes buffer, pH 7.4.
to be ﬁlled with electron dense material. When puriﬁed native
cores were reacted with baculovirus recombinant-expressed and
puriﬁed VP6 (of bovine rotavirus RF strain), large numbers of VP6
tubules, many DLPs and many free VP6 trimers were seen (Fig. 4D).
In some cases the cores were wrapped by VP6 originating from the
tubules. Transcapsidation was  a quick event and almost complete at
ores opened by EGTA and restabilised by Mg2+, spermidine3+, and cobalthexamine3+.
staining with ethidium bromide. Lane 1: Puriﬁed DLPs; lane 2: puriﬁed cores:
 lane 5: cores + 400 M EGTA + VP6; lane 6: cores + 400 M EGTA + 1.6 mM MgCl2
: cores + 400 M EGTA + 300 M spermidine3+ after 1 min; lane 9: cores + 400 M
balthexamine3+ after 1 min + VP6; lane 11: 400 M EGTA + 1.6 mM MgCl2 + VP6.
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Fig. 4. Electron microscopy of different rotavirus preparations. (A) Puriﬁed native cores; (B) Cores opened with 600 M EGTA; C. Cores opened with 600 M EGTA and treated
with  2.4 mM MgCl2 after 1 min; (D) Puriﬁed native cores reacted with baculovirus recombinant-expressed and puriﬁed VP6; (E) Restabilised cores as shown in C, treated
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may have been due to transcapsidation of stabilised cores and not
only the presence of possibly unopened cores.
Table 2
Rescue of infectivity from rotavirus cores after various treatments in vitro followed
by  liposome-mediated transfection into KJ cells.
Treatment of cores Titration of yield (TCID50/ml)
Exp 1 Exp 2 Exp 3
None Neg Neg Neg
EGTA Neg Neg Neg
EGTA + Mg2+ Neg Neg Neg
EGTA + VP6 100* Neg 2000
EGTA + Mg2+ + VP6 1000* 10,000 20,000
EGTA + spermidine3+ Neg ND+ Neg
EGTA + spermidine3+ + VP6 100 ND 20,000ith  puriﬁed VP6. The calibration bar indicates 100 nm [see Text for details]. A high
 min  after addition of VP6 (results not shown). When restabilised
ore structures (opened with 0.6 mM EGTA and treated with 5 mM
gCl2 1 min  later) were reacted with VP6, many DLPs were seen as
ell, some appearing to be empty, some containing electron-dense
aterial (Fig. 4E). The transcapsidation process was  less effective,
hen the preparations of puriﬁed VP6 lacked tubules, suggesting
hat the VP6 concentration was too low (results not shown).
.5. Infectivity of native cores, reconstituted cores and in vitro
econstituted DLPs
Preparations of puriﬁed native cores, opened cores, reconsti-
uted cores, and of DLPs reconstituted from both, native and
econstituted cores with baculovirus recombinant-expressed VP6
ere transfected into conﬂuent monolayers of MA104 cells. Great
are was taken to avoid contamination. The results of three inde-
endent experiments are shown in Supplementary Table S1 (ST1).
hey demonstrate some infectivity of reconstituted cores after
ranscapsidation with VP6, with DLPs produced by encapsidation of
ative cores serving as positive controls (Chen and Ramig, 1993b).
To investigate whether infectivity of stabilised, VP6-
ranscapsidated RV cores was due to reclosing of opened cores or to
he presence of residual unopened cores, cores were opened with
GTA and stabilised with Mg2+ after 30, 60, and 120 s at which time
oints recombinant VP6 was added; at that time points, aliquots of
pened cores were also reacted with VP6 without prior treatment
ith Mg2+. Only in the cases where cores were stabilised with
g2+ within one min  was infectivity recovered (Supplementary
able S2, ST2). [This experiment was once reproduced with exactly
he same result.] However, with these data alone, the rescue ofgniﬁcation of panel B is provided in Supplementary Figure S2.
infectivity shortly after opening and stabilisation of cores cannot
be interpreted with certainty as rescue derived from stabilised
and not from unopened cores. The issue was addressed further
by testing in parallel the infectivity of DLPs reconstituted from
EGTA-opened cores to which VP6 was added in the presence
or absence of Mg2+, spermidine3+ or cobalthexamine3+. In three
experiments it was  shown that stabilisation of cores permitted the
rescue of more infectivity by transcapsidation with VP6 (followed
by transfection) than was  possible after addition of VP6 alone
(Table 2). This suggests that at least some of the infectivity rescuedEGTA + cobalthexamine3+ Neg ND Neg
EGTA + cobalthexamine3+ + VP6 1000 ND 5000
None + Mg2+ + VP6 ND ND 20,000
* Tested twice, + Not done.
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Fig. 5. In vitro packaging of 32P-labelled rotavirus mRNA (transcribed from DLPs)
into particles: Protection from RNase I digestion. 0.8% agarose gel, MOPS-Tris buffer
10  mM,  pH 7.7. (A) Gel unﬁxed, stained with ethidium bromide; (B) Gel ﬁxed, silver
stained; (C) Gel ﬁxed, dried and autoradiographed. Lane 1: DLPs; lane 2: native RV
cores; lane 3: cores + RV mRNA + EGTA + packaging mixture; lane 4: as lane 3 + RNase
I;  lane 5: cores + mRNA + EGTA + packaging mixture + VP6; lane 6: as lane 5 + RNase
I;  lane 7: mRNA [the dsRNA seen in panels A and B originates from the DLPs which
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Fig. 6. Non-speciﬁcity of packaging of ssRNA into rotavirus cores in vitro, Lane
1:  DLPs; lane 2: native RV cores; lane 3: cores + EGTA; lane 4: cores + EGTA + 32P-
labelled RV RNA 11 + packaging mixture; lane 5: as lane 4 + RNase I; lane 6: RVave been pelleted by ultracentrifugation after the in vitro transcription reaction
nd may  have been partially damaged]; lane 8: as lane 7 + RNase I. Cores amount
sed: 60 ng/20 l, or approximately 5 × 108 particles.
.6. Packaging of rotavirus RNA produced in vitro into opened
nd stabilised cores
Based on these results, RV cores were opened with EGTA
nd reconstituted with divalent cations in the presence of small
mounts (<10 ng) of 32P-radiolabelled, (+)ss RV RNA, produced in
itro either from DLPs (all 11 segments) or from T7 promoter-driven
DNAs contained in plasmids or amplicons (individual segments).
o optimise packaging, a ‘packaging mixture’ was devised and opti-
ised (see Section 2), which was derived from the solution used
y L Mindich’s group for packaging of bacteriophage phi6 ssRNA
egments into cores in vitro (Qiao et al., 1995). After cation addi-
ion, cores were treated with RNase I and the reaction products
nalysed on non-denaturing agarose gels. It was shown (Fig. 5A–C)
hat opened RV cores could successfully package radiolabelled RV
NA (Fig. 5C, lane 3). The radiolabelled RNA was  protected from
Nase I which digests released genomic dsRNA and excess exter-
al ssRNA (Fig. 5C, lane 4). The difference in ssRNA binding to cores
efore and after RNase I treatment testiﬁes to the high afﬁnity of
V cores to ssRNA (Fig. 5C, lanes 3 and 4) and also to the fact that
xternally bound ssRNA is accessible to RNase I digestion. More-
ver, the reconstituted core structures could be transcapsidated
ith VP6 and still contain the in vitro packaged ssRNA in an RNase
-protected form (Fig. 5C, lane 6). Experiments to show replica-
ion of ssRNA packaged into reconstituted core particles remainedRNA11; lanes 7–9: treatment as in lanes 4–6, respectively, using 32P-labelled HIV-2
RNA751; lanes 10–12: treatment as in lanes 4–6, respectively, using 32P-labelled
HIV-2 RNA1104.
unsuccessful (results not shown). Due to small quantities of core
particles which contained packaged ssRNAs, their density was  not
assessed. However, they comigrated with native cores during elec-
trophoresis on non-denaturing gels.
In order to explore the speciﬁcity of ssRNA packaging, opened RV
cores were tested for their ability to package heterologous ssRNA.
Transcripts of ssRNA (751–1104 bases in length), obtained from
HIV-2 amplicons, were tested in parallel with segment-speciﬁc RV
ssRNA transcripts (667–1061 bases in length). It was reproducibly
found that the heterologous RNAs were packaged to an extent very
similar to that of packaging of RV RNA (Fig. 6, lanes 7–9 and 10–12
in comparison with lanes 4–6). Various measures, e.g. heat pre-
treatment of viral RNA (Supplementary Figure S4), variation of the
ion concentrations of the packaging mixture (Supplementary Fig-
ure S5), or elevating the packaging reaction temperature to 37 ◦C
(results not shown) did not succeed in increasing packaging speci-
ﬁcity.
3.7. Packaging competition assays
Based on these observations, the speciﬁcity of ssRNA packaging
was  explored further by competitive packaging assays in which
constant amounts of 32P-labelled RV and HIV-2 RNAs competed for
packaging with varying amounts of unlabelled, homologous or het-
erologous RNAs. Fig. 7 illustrates a typical experiment. The degree
of decrease of packaged radiolabelled RNA by various amounts of
unlabelled RNA was  quantitated by the Image J program, taking
the density of the not competed packaged radiolabelled material
as 100%. The data of three experiments are shown in Table 3. From
a number of such experiments the percentage decrease of pack-
aging of radiolabelled ssRNA by competing unlabelled ssRNA was
plotted against the amounts of unlabelled RNA in the reaction.
The data are summarised in Supplementary Figure S6. The vari-
ance of experimental values around the straight lines [calculated
by linear regression] was rather large (even in the homologous
competition assays). The slopes and intercepts of homologous and
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Fig. 7. Inhibition of packaging of radiolabelled ssRNA by cold ssRNA (basis for com-
petitive packaging assay), Lane 1: DLPs; lane 2: native RV cores; lane 3: cores + EGTA;
lane 4: as lane 3 + packaging mixture; as lane 4 + radiolabelled RV RNA7; lane 6: as
lane 5 + RNase I; lanes 7–10: as lane 6, with unlabelled RV RNA added before packag-
ing: 100 ng (7), 50 ng(8), 25 ng (9), 13 ng (10); lane 11: cores + EGTA + radiolabelled
HIV-2 1104 RNA + packaging mixture + RNase I; lane 12: as lane 11, with 100 ng
of  unlabelled HIV-2 1104 RNA added before packaging. * Determined by densito-
metric analysis of scanned autoradiograph using the Image J programme ‘Image J’
(http://rsbweb.nih.gov/ij/).
Table 3
Competitive inhibition of packaging of radiolabelled RNA by unlabelled homologous
or  heterologous RNA.
Exp/Track Radiolabelled RNA Unlabelled RNA (ng) % packageda
U73-3, 6 RV RNA 7 – 100
7  “ RV RNA 7 (105) 31
8  “ HIV 1100 RNA (125) 65
U74-4, 6 RV RNA 7 – 100
7  “ RV RNA 7 (105) 40
9  “ HIV 1100 RNA (125) 65
U77-2, 6 RV RNA 11 – 100
7  “ RV RNA11 (132) 30
8  “ “(66) 63
10  “ HIV 750 RNA (111) 66
11  “ “(56) 76
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Table 4
Competition for packaging experiments: slopes and intercepts of linear regression
functions in which the percent inhibition of packaging of radiolabelled RNA was
plotted against the amounts of added unlabelled RNA.
Radiolab. Cold Slope Intercept N R P Slope
RNA RNA ratio
RV RV y = 0.384x + 3.422 16 0.853 <0.001
RV  HIV y = 0.341x + 6.009 12 0.783 <0.003 0.89
HIV  HIV y = 0.276x + 8.226 16 0.732 <0.001
HIV RV y = 0.239x + 11.453 28 0.730 <0.001 0.87
RV  hom HIV hom 0.72
RV het HIV het 0.70a Determined by densitometric analysis of autoradiograph using program ‘Image
’.
eterologous competitive packaging reactions (Supplementary Fig-
re S6; Table 4) were not signiﬁcantly different by ANCOVA
ovariance analysis (P > 0.05), supporting the statement made
bove in assessing Fig. 6.
Despite extensive attempts at optimisation, the packaging assay
as of low speciﬁcity, and the procedure was thus of insufﬁcient
uality to discriminate putative packaging signals on native RV
NAs or their mutants.
. Discussion
Rotavirus core assembly in the infected cell is tightly controlled
ut not well understood. The inability of in vitro production of func-
ional cores de novo is a major stumbling block in engineering viable
V particles from its components, whilst transcapsidation of native
ores under appropriate conditions in vitro can achieve restorationThe slopes and intercepts were found not to differ signiﬁcantly by the ANCOVA test
(http://ude1.edu/∼mcdonald/statancova.html).
of full infectivity (Trask and Dormitzer, 2006). Better knowledge of
core assembly will help on the way  towards developing a helper
virus-free reverse genetics system for RVs (Trask et al., 2010). The
availability of such a system would permit the detection of RNA
packaging signals, e.g. as described for one bluetongue virus RNA
segment (Matsuo and Roy, 2009).
The work presented here was carried out to deﬁne the condi-
tions under which RV ‘opened cores’ are produced and to attempt
reconstitution of ‘open cores’ in vitro with possible restoration of
functions. The minimum concentration of EGTA sufﬁcient to open
cores was  determined and, conversely, the minimum concentra-
tions of di- and trivalent cations needed to stabilise cores. We
observed that RV core preparations decompose within one week
at 4 ◦C, but are much more stable when stored in the presence
of 200 M Ca2+ (results not shown). The requirements of divalent
cations to stabilise TLPs (Ca2+; Estes et al., 1979) and VP6 assem-
blies (Zn2+; Erk et al., 2003) have been investigated previously. In
the absence of divalent cations (mainly Ca2+) RV cores explode, lib-
erating their genomic dsRNA. In their isolated form genomic RV
dsRNAs have a minimal persistence length of 1125 A˚, i.e. double the
diameter of RV cores (Kapahnke et al., 1986). Divalent and trivalent
cations were shown to reconstitute core structures but only within
a very tight time frame after initiation of a treatment with EGTA.
These data and the fact that baculovirus recombinant-expressed,
empty core-like particles were not broken up by 50× the amount
of EGTA sufﬁcient to open native cores speak for the interaction
of the cationic compounds with the genomic dsRNA inside native
cores rather than for their interaction with proteins.
Rotavirus cores are difﬁcult to work with since they have a ten-
dency to aggregate.
Native RV cores puriﬁed from DLPs loose the monodispersity
of the DLP preparation and form aggregates of 13–17 particles as
described previously (Bican et al., 1982; Labbé et al., 1991; Zeng
et al., 1994). Only DOC and SDS were reported to desaggregate the
VP2 protein, the main scaffolding component of the cores (Labbé
et al., 1991). Here we  determined the minimum concentration of
DOC needed to resolve core aggregates whilst maintaining their
particular structure. We  considered using DOC  as desaggregating
agent for core preparations, but as it acts as an emulsiﬁer and mild
detergent, we abstained from using it in transcapsidation experi-
ments.
It was found that ‘opened cores’ could be reconstituted into
core-like structures by the addition of divalent or trivalent
cations (Ca2+, Mg2+, spermidine3+, cobalthexamine3+) to ‘opened
core’-EGTA mixtures within the narrow time window of approx-
imately 1–2 min  as evidenced by EM and electrophoresis on
non-denaturing gels. The question whether such reconstituted,
‘restored’ cores are functional or whether residual non-opened
ones maintain function is important in the context. Some EM
evidence and viral infectivity data argue at least in part for
s Rese
s
r
r
b
e
m
r
m
1
(
i
V
e
a
t
(
d
o
H
c
c
t
t
i
e
p
a
o
t
P
c
w
t
i
p
R
t
o
f
s
s
u
r
v
i
r
p
n
r
i
o
i
r
i
p
W
t
2
T
r
aU. Desselberger et al. / Viru
ome function of ‘restored’ cores. Although, upon opening, cores
elease their genomic dsRNA quickly, upon treatment with cationic
eagents within 1–2 min  of opening electron-dense materials can
e observed (also after transcapsidation with VP6) that is consid-
red to contain components of the genome including the replication
achinery.
Preparations of cores and ‘opened cores’ did not have
esidual infectivity on their own when tested in lipofectamine-
ediated transfection assays (Bass et al., 1992; Chen and Ramig,
993b). When baculovirus recombinant-expressed puriﬁed VP6
Charpilienne et al., 2002) was added to native and ‘restored’ cores,
nfectivity was partially rescued, since cores transcapsidated with
P6 regain transcriptase activity (Kohli et al., 1993). From our
xperience, VP6 preparations which actively transcapsidated cores,
lways contained tubules. The formation of tubules depends on
he concentration of VP6, on pH and ionic strength of the solution
Lepault et al., 2001). By non-denaturing gel analysis, transcapsi-
ated cores were seen as a ladder-like set of particle subpopulations
f different size. At present, their true composition is speculative.
owever, by EM VP6-encapsidated cores (native or ‘restored’) were
learly seen. The infectivity differences of preparations of ‘opened
ores’ and ‘restored’ cores after VP6 transcapsidation in part signify
he differences of infectivity of unopened and ‘restored’ cores, but
he data were very variable. This may  be due to the tendency of
solated native cores to form aggregates (Labbé et al., 1991; Zeng
t al., 1994; this work).
We demonstrated that radiolabelled naked RV (+) ssRNAs can be
ackaged in vitro into opened and reconstituted cores where they
re partially protected from RNase I treatment. [The great afﬁnity
f cores to ssRNA has been shown for bluetongue virus, belonging
o another genus of the Reoviridae family (Loudon and Roy, 1992).]
reliminary experiments did not detect any infectivity of restored
ores obtained after a packaging reaction and after transcapsidation
ith VP6 (results not shown). So far, no evidence has been obtained
hat RV RNA packaged in vitro is replicated.
In further experiments it was shown that the packaging of ssRNA
nto core-like structures is not virus-speciﬁc. The kinetics of com-
etitive packaging of viral homotypic (RV) and heterotypic (HIV-2)
NAs conﬁrmed a lack of speciﬁcity of RNA packaging, rendering
his procedure unsuitable to test for packaging signals of wildtype
r mutant RV RNAs in vitro.
Numerous attempts to introduce RV ssRNA into ‘opened cores’
ollowed by treatment with divalent or trivalent cations, transcap-
idation with VP6 and infectivity testing in transfection assays have
o far been unsuccessful to rescue infectious RV (U Desselberger,
npublished results). This identiﬁes a main difﬁculty in attempting
econstruction of the early morphogenesis events of RV particles in
itro. Native isolated cores are relatively stable when suspended
n the presence of divalent cations (200 M Ca2+, unpublished
esults), but break apart in water within a few days. The decom-
osition process is very rapid as soon as divalent cations which
eutralise the overall negative charge of the genomic dsRNA are
emoved, e.g. by chelating agents. Under the aspect of dsRNA ﬂex-
bility, ‘one has to assume an intimate protein–RNA interaction or
ther forces in order to induce additional bending and packaging
nto the core’ (Kapahnke et al., 1986). Thus, it is futile to attempt
epackaging of free RV dsRNA into cores. In natural infections it
s the single stranded RNA segments of positive polarity that are
ackaged (Gallegos and Patton, 1989; Patton and Gallegos, 1990).
hilst the opening of cores appears to be reversible within narrow
ime limits, the loss of genomic dsRNA segments is irreversible.
A carefully balanced presence of NSP2 and NSP5 (Berois et al.,003; Patton, 2001; Schuck et al., 2001; Taraporewala et al., 1999;
araporewala and Patton, 2001) may  be required to give such
econstitution experiments in vitro a chance of success. NSP2 has
n NTPase activity (Taraporewala et al., 1999) and possibly acts as aarch 178 (2013) 252– 263 261
molecular motor for packaging (Patton et al., 2003). NSP5 interacts
strongly with VP2 (Berois et al., 2003) and is a possible modula-
tor of the NSP2 function (Patton et al., 2003). Both NSP2 and NSP5
are needed for the formation of viroplasms during virus replication
(Fabbretti et al., 1999), and there is evidence that RNA replication
occurs in the viroplasm (Silvestri et al., 2004). Inhibition of NSP2
and NSP5 expression by siRNA or intrabodies prevents RNA replica-
tion and the production of infectious virus (Campagna et al., 2005;
Silvestri et al., 2004; Vascotto et al., 2004). It is also possible that
viral proteins VP1 and VP3 have to be added to in vitro packaging
mixtures; this remains to be explored.
Furthermore, the recent ﬁndings that RV viroplasms interact
with lipid droplets in the infected cell and that compounds dis-
turbing the lipid droplet homoeostasis decrease the production of
infectious RV progeny (Cheung et al., 2010) may  explain the lack
of success so far of in vitro reconstitution experiments for func-
tional cores. It is likely that the in vitro conditions explored did
not appropriately mimic  the intracellular environment of RV early
morphogenesis.
For the three-segmented dsRNA phages of the Cystoviridae fam-
ily (phi6 and others) an in vitro packaging system has been devised
(Olkkonen et al., 1990; Qiao et al., 1997; Mindich, 1999; Poranen
et al., 2001; Poranen and Tuma, 2004): two  viral enzymes, the
packaging NTPase (P4) and the RdRp (P2), have been found to be
essential for the nucleation step in addition to the major procap-
sid protein (P1). Once the single-stranded RNAs of positive polarity
are packaged, they can be replicated, and by the addition of the
nucleocapsid coat protein (P8) subviral particles be made that
are infectious under speciﬁed conditions. However, the cystovirus
packaging system is based on the pre-existence of an empty pro-
capsid into which the ss(+)RNA segments are pulled in a particular
order. For RV, the core-ﬁlling model of packaging is much less likely
than the concerted packaging model (McDonald and Patton, 2011).
A stunning example of a mammalian virus produced in a cell-free
extract de novo with relatively simple means it that of poliovirus
(Molla et al., 1991).
It is hoped that an in vitro system for the reconstitution of
rotavirus particles from its components can be devised. Following
unsuccessful early attempts (Gorziglia and Collins, 1992; Silvestri
et al., 2004), recently helper virus-dependent reverse genetics (RG)
systems have been established for RVs (Komoto et al., 2006; Troupin
et al., 2010; Trask et al., 2010), but attempts so set up a helper virus-
independent RG system for RVs have so far been elusive (Richards
et al., 2013, and unpublished results of several other research
groups). The availability of a helper virus-free system of reverse
genetics (‘génétique inverse’) for RVs will have far reaching con-
sequences for basic and applied research. In vitro reconstitution of
infectious virus as recently achieved for bluetongue virus (Lourenco
and Roy, 2011) will be a possibility to explore for RVs. Reconstitu-
tion of the RV core complex in vitro from its components (proteins
and RNAs) to functional entities will be essential to resolve the
sequence of events during early RV particle morphogenesis.
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